Biofrontera to Present at the 3rd Annual ROTH Healthcare Opportunities Conference
WOBURN, MA / ACCESSWIRE / September 25, 2024 / Biofrontera Inc. (NASDAQ:BFRI), a biopharmaceutical company specializing in the commercialization of...
Month: September 2024
Quasar Medical Acquires Ridgeback Technologies
Quasar Medical Is Expanding Its Capabilities By Adding Balloon CathetersSAINT PAUL, MN / ACCESSWIRE / September 25, 2024 / Quasar...
Championing HIV Services for LGBTQ+ Youth
NORTHAMPTON, MA / ACCESSWIRE / September 25, 2024 / Gilead Sciences As a young gay professional, Terrell Parker spent several...
Cosmos Health Reports Strong 160% Increase in 2024 YTD Sales on Amazon UK for Its Proprietary Brands
CHICAGO, IL / ACCESSWIRE / September 25, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified,...
Quantum BioPharma to Present at Global Growth and Investment Conference Presented by ArcStone Securities and Investments and Kingswood US
TORONTO, ON / ACCESSWIRE / September 25, 2024 / Quantum BioPharma Ltd. (formerly, FSD Pharma Inc.) (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma" or...
Berenson Acquisition Corp. I Announces Liquidation
New York, New York--(Newsfile Corp. - September 25, 2024) - Berenson Acquisition Corp. I, (NYSE American: BACA) a special purpose...
Red Light Holland’s Wholly Owned Subsidiary Happy Caps Partners with Trailbridge Mushroom Farms to Expand Mushroom Home Grow Kit Production in the USA
Toronto, Ontario--(Newsfile Corp. - September 25, 2024) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light...
InBrain Pharma to Present Positive Results from Its DIVE-I Phase I/II Clinical Trial for Parkinson’s Disease at the Congress of Parkinson’s Disease and Movement Disorders from September 27 to October 1 in Philadelphia
Lille, September 25, 2024 - InBrain Pharma, a biopharmaceutical company specialized in neurodegenerative diseases, will present the positive results of its...
INTASYL Technology and Compounds to be Focus of Presentation at 20th Annual Meeting of Oligonucleotide Therapeutics Society
--Data will be presented at the conference in October in MontrealMarlborough, Massachusetts--(Newsfile Corp. - September 25, 2024) - Phio Pharmaceuticals...
Sanner Group acquires Gilero to expand its global medical device offering
Sanner Group acquires Gilero to expand its global medical device offering Acquisition drives Sanner Group’s mission to offer a suite...
Incredable(TM) (Formerly Ready Doc(R)) Launches New Provider App and Announces Attendance at NAMMS Conference
As part of its recent rebrand, Incredable™ unveils a mobile app designed to streamline credentialing processes, reduce manual work, and...
Kronos Bio to Present Data at ACR Convergence 2024 to Support p300 KAT Inhibition as an Approach to Anti-Inflammatory Therapy
– Through selective inhibition of proinflammatory transcription, p300 KAT inhibition modulates the activity and function of multiple pro-inflammatory signaling pathways...
GEN Announces Positive Phase 2 Clinical Trial Results for GN-037 Topical Cream in Patients With Mild to Moderate Plaque Psoriasis
ANKARA, TURKEY / ACCESSWIRE / September 25, 2024 / GEN Pharmaceuticals (GENIL.IS), a leading Turkish pharmaceutical company, has announced the...
GRI Bio (NASDAQ: GRI) to Participate in a Virtual Investor CEO Connect Segment
Live video webcast on Wednesday, October 2nd at 12:00 PM ET LA JOLLA, CA, Sept. 25, 2024 (GLOBE NEWSWIRE) --...
Africa CDC and IAVI Sign Memorandum of Understanding to Enhance Vaccine and Antibody Research Capacity in Africa
NEW YORK, NY / ACCESSWIRE / September 25, 2024 / The Africa Centres for Disease Control and Prevention (Africa CDC)...
Health Care Service Corporation Adds First-Line TMS Coverage for Adolescents
Policy update increases access for millions covered by HCSC BlueCross BlueShield policiesMALVERN, Pa., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Neuronetics,...
Jaguar Health to Participate in the Lytham Partners Fall 2024 Investor Conference on October 1, 2024
SAN FRANCISCO, CA / ACCESSWIRE / September 25, 2024 / Jaguar Health, Inc. (NASDAQ:JAGX) today announced that Lisa Conte, the...
Entera Bio and OPKO Health Provide Update on PK/PD Results of Oral Oxyntomodulin (GLP-1/Glucagon) Peptide Tablet Candidate for Obesity and Metabolic Disorders
JERUSALEM and MIAMI, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX) (Entera), a leader in the development...
NLS Pharmaceutics Ltd. Announces Expected Implementation of 1-for-40 Reverse Share Split
ZURICH, SWITZERLAND / ACCESSWIRE / September 25, 2024 / NLS Pharmaceutics Ltd. (Nasdaq:NLSP)(Nasdaq:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage...
UK’s Largest Greenhouse Complex, Thanet Earth, Adopts Intelligent Bio Solutions’ Fingerprint Drug Test to Enhance Workplace Safety
NEW YORK, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical...